EQS-News: Telekom Austria AG / Announcement of the Results of the General Meeting Telekom Austria AG: Voting results Annual General Meeting 2025 03.06.2025 / 16:36 CET/CEST Announcement of the Results ...

CET/CEST Press Release AUSTRIACARD HOLDINGS presents new AI-driven Anti-Money Laundering solution at Money 20/20 Introducing the “Digital Taskforce for AML” – a next-generation Agentic AI solution ...

Dividend/AGM/EGM UNIQA Insurance Group AG: Dividend Announcement 03.06.2025 / 10:44 CET/CEST The issuer is solely responsible for the content of this announcement.

Following the launch of its Onshore Bond on Adviser Platform last month, Aviva is pleased to announce its latest technology developments, in partnership with FNZ, as part of its ongoing commitment to ...

Strategic Company Decision wienerberger acquires MFP in Ireland and strengthens position in key growth markets 03.06.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this ...

ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical ...

The long-standing issue of Western Sahara has seen a significant diplomatic breakthrough, as the United Kingdom has officially recognised the Moroccan autonomy initiative, presented ...

Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal's footprint in Latin America ...

Vienna-based political scientist Alina Brad explores how the expectation of future CO 2 removal technologies is already influencing EU climate policy.

Joint Venture Green light for joint venture between AGRANA and INGREDION in Romania 02.06.2025 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement.

Disposal Mayr-Melnhof Karton AG: MM closes sale of TANN Group 02.06.2025 / 11:23 CET/CEST The issuer is solely responsible for the content of this announcement.

BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential ...